Torben Andersen-Mourits

Esbjerg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Journal: Blood advances

Published: March 29, 2021

Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.

Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 14, 2018

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

Journal: European journal of haematology

Published: November 03, 2015

Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.

Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.

Journal: British journal of haematology

Published: October 09, 2015

Status and perspectives on chronic myeloproliferative neoplasm treatment

Status and perspectives on chronic myeloproliferative neoplasm treatment

Journal: Ugeskrift for laeger

Published: May 14, 2015

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia.

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: September 12, 2014

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.

Journal: Leukemia research

Published: February 20, 2014

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Journal: British journal of haematology

Published: April 09, 2013

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

Journal: British journal of haematology

Published: January 28, 2013

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 06, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026